Avid Bioservices Inc (CDMO)

[jessme]

DNA PR on Avastin long-term for ovarian CA was pathetic. Pfizer's new products will hopefully neutralize some of its horrible reverses lately. BMY did its DD and got a good-to-great pipeline when it bought Medarex. PPHM is at least equal to Medarex.

. Bristol-Myers Squibb (BMS) will buy biopharmaceutical company, Medarex, for $2.1 billion,

BMY did its DD
Apparently their DD didn't like Peregrine.

PPHM is at least equal to Medarex.

Not according to any standards we have seen. Sorry, a Stason deal doesn't come close. These other drugs may be inferior to bavi, but there is one important difference. Many are on the market and making billions for their companies.

Down over 10% now. Peregrine has jumped into Second place.


Laggards in Price Performance (Intraday)
Molecular Insight Pharmaceutica [mipi] -10.07%
Peregrine Pharmaceuticals Inc. [pphm] -9.45%
Antigenics Inc. [agen] -9.30%
Codexis, Inc. [cdxs] -7.05%
China Biologic Products, Inc. [cbpo] -6.89%
AEterna Zentaris, Inc. [aezs] -6.62%
Pluristem Therapeutics, Inc. [psti] -6.35%
Eurand N.V. [eurx] -5.26%
Dendreon Corporation [dndn] -5.22%
Cyclacel Pharmaceuticals, Inc. [cycc] -4.61%